Hospital Universitario Virgen de La Arrixaca

EL Palmar (EL Palmar), Murcia 30120

2 studies enrolling now · 2 studies all time

What they study most

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, HER2-positive Breast Cancer

Studies at this site

• A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) — Recruiting now
• RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive — Recruiting now